Memopryl Ingredients: What’s in the Formula?

Most supplement ingredient analyses stop at listing what's in the bottle and citing a study or two per compound. This one doesn't. Memopryl's formula contains eight ingredients, and the research behind them varies considerably — in quality, in the populations studied, in the dosage ranges that produced measurable effects, and in the mechanisms that distinguish each compound's role in the stack.

This article is part of the HathawayMD Memopryl review series. It will not contain an affiliate link. The ingredients analysis is a reference document, not a sales tool. The complete Memopryl review covers the product overview, pricing, and refund policy. The safety and drug interactions article covers the interaction profile in full. Start here if what you need is the science on what Memopryl actually contains.

One note before the analysis: Memopryl does not disclose individual ingredient dosages. The formula is a proprietary blend. This means the research context below can establish what doses have been studied and shown effects — but it cannot confirm whether Memopryl reaches those thresholds. That opacity is documented transparently here, not glossed over.

The Proprietary Blend Problem — and What It Means for Your Stack

When a supplement discloses only the total blend weight and not individual ingredient amounts, it creates two practical issues. First, you cannot confirm whether any individual ingredient reaches the dose range that produced effects in published research. Second, if you take other supplements or prescription medications, you cannot accurately track your daily intake of compounds that overlap between products.

For most healthy adults taking no other supplements, this is a manageable limitation. For anyone building a deliberate supplement stack — particularly if other nootropics or cholinergic compounds are already part of the routine — the opacity matters. Three of Memopryl's eight ingredients act on the same biological pathway (the cholinergic system). Understanding which three and why is part of what this analysis covers.

Ingredient 1: Ginkgo Biloba

Ginkgo Biloba extract is derived from one of the world's oldest tree species and has been used in traditional Chinese medicine for centuries. In modern cognitive research, the primary mechanisms studied involve cerebrovascular effects (improved cerebral blood flow), antioxidant activity (primarily from flavonoids and terpenoids), and anti-platelet aggregation effects.

The clinical picture on Ginkgo Biloba is more nuanced than most supplement marketing acknowledges. A Cochrane review of 36 trials found some evidence supporting modest benefit in age-related cognitive decline — but effect sizes were inconsistent across studies, and the evidence was rated as mixed in quality. A large NIH-funded trial (the GEM study) found no significant prevention of dementia in older adults taking 240 mg daily over several years. For day-to-day cognitive support in healthy adults, the evidence base is more limited than for Bacopa or Alpha-GPC.

Effective doses in most studied contexts ranged from 120 mg to 240 mg daily of a standardized extract (typically 24% flavone glycosides, 6% terpene lactones). Memopryl's per-ingredient dose is undisclosed.

Drug interaction note: Ginkgo Biloba has antiplatelet properties and should be used cautiously alongside blood thinners including warfarin and aspirin. This is a secondary interaction consideration — St. John's Wort's interaction profile is more clinically significant in this formula.

Ingredient 2: Phosphatidylserine

Phosphatidylserine (PS) is a phospholipid that forms part of the structural layer of neuronal cell membranes. It is synthesized in the body and also obtained through diet, primarily from soy-derived sources in most supplements (bovine-derived PS was used in earlier research but is no longer common).

Phosphatidylserine has something that most nootropic ingredients don't: a qualified health claim from the FDA. Specifically, the FDA authorized a claim (in 2003) that very limited and preliminary scientific research suggests PS may reduce the risk of dementia and cognitive dysfunction in the elderly — with the explicit caveat that the evidence is limited and not conclusive. This is not FDA approval and not a drug claim. It is a qualified health claim, which represents a lower standard of evidence than a drug approval. It is still notable as one of the few acknowledged connections between a dietary supplement and a cognitive health claim.

Research on PS in aging adults has generally used 100 mg to 300 mg daily. A 2010 study in older adults with memory complaints found improvements in delayed word recall with 300 mg daily over 6 months. Effects in younger, healthy adults are less well-documented.

Ingredient 3: Bacopa Monnieri

Bacopa Monnieri is the ingredient in Memopryl's formula with the strongest and most consistent evidence base for the specific outcome of memory improvement. The research is also the most important to understand correctly — because Bacopa is a slow-acting compound and most of the studies showing significant results used 12-week protocols or longer.

The mechanism involves modulation of hippocampal function, enhanced dendritic branching and synaptogenesis (growth of neuronal connections), antioxidant activity, and some adaptogenic effects on cortisol response. Multiple randomized controlled trials in healthy older adults and adults with mild cognitive complaints have found statistically significant improvements in delayed word recall, visual processing speed, and working memory. A well-cited 2002 study by Roodenrys et al. found significant improvements in new information retention at 300 mg daily over 12 weeks. A 2008 meta-analysis confirmed the pattern of modest but real effects on delayed recall specifically.

The critical variable: many users try a nootropic for 2 to 3 weeks and evaluate from there. For Bacopa, this evaluation timeline predates the window in which the research shows effects. The 12-week minimum in most positive trials isn't marketing language — it reflects the compound's mechanism, which involves gradual neuronal structural changes rather than acute neurotransmitter shifts.

Effective doses in most studied contexts: 300 mg to 450 mg daily of a standardized extract (typically 50% bacoside content).

Ingredient 4: Alpha-GPC

Alpha-glycerylphosphorylcholine (Alpha-GPC) is a highly bioavailable choline compound that crosses the blood-brain barrier efficiently. Once in the brain, it provides choline as a direct precursor to acetylcholine — the neurotransmitter most directly associated with memory encoding, consolidation, and retrieval.

Alpha-GPC is one of the more pharmacologically active ingredients in Memopryl's formula. Research has used it in both healthy adults and adults with mild cognitive decline. A notable Italian clinical trial used 400 mg three times daily (1,200 mg/day total) in adults with early Alzheimer's and found significant improvements in cognitive assessment scores over 6 months. Studies in healthy adults have used lower doses (250 to 600 mg daily) with effects on attention, working memory, and GH secretion.

Alpha-GPC is the first of three cholinergic-pathway ingredients in this formula. Understanding its mechanism — increasing acetylcholine supply — is the foundation for understanding why the interaction concern with prescription Alzheimer's medications exists. See the safety review for the full discussion.

Ingredient 5: N-Acetyl-L-Carnitine (ALCAR)

N-Acetyl-L-Carnitine is the acetylated form of L-Carnitine. The acetyl group allows it to cross the blood-brain barrier more efficiently than standard L-Carnitine. Once in the brain, ALCAR serves two primary roles: supporting mitochondrial energy metabolism in neurons (delivering fatty acids for ATP production) and contributing to acetylcholine synthesis.

The dual function makes ALCAR the second cholinergic-pathway ingredient in Memopryl's formula — it doesn't act as dramatically on acetylcholine as Alpha-GPC or Huperzine-A, but its mild cholinergic contribution is additive. Research on ALCAR has focused primarily on older adults. A 2003 meta-analysis of 21 trials found modest but consistent improvements in cognitive assessment scores in adults with mild Alzheimer's disease or age-associated memory impairment over 3 to 12 months. Effects in younger, healthy adults are less robust.

ALCAR is also studied for its role in managing mental fatigue under sustained cognitive load — a more relevant benefit for working-age adults than the long-term neuroprotection research might suggest.

Ingredient 6: Huperzine-A

Huperzine-A is derived from club moss (Huperzia serrata) and works through a mechanism that is pharmacologically specific: it inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine. By slowing the breakdown of acetylcholine, Huperzine-A effectively raises acetylcholine availability in the synaptic cleft.

This mechanism is nearly identical to how a class of FDA-approved prescription drugs works — cholinesterase inhibitors including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne) are the standard pharmacological treatment for Alzheimer's disease. This does not make Huperzine-A a drug or a treatment for Alzheimer's — the compound is structurally different and has not gone through the clinical trial process required for drug approval. It does mean the mechanism is well-understood and that the interaction concern with prescription cholinesterase inhibitors is real and specific.

Huperzine-A is the third and most pharmacologically direct cholinergic-pathway ingredient in this formula. Together with Alpha-GPC and ALCAR, the formula creates a triple-pathway cholinergic stack: increased supply (Alpha-GPC), synthesis support (ALCAR), and reduced breakdown (Huperzine-A). For context on who this matters for, see the drug interactions review.

Research on Huperzine-A for cognitive support in healthy adults is less extensive than for Bacopa or PS. Chinese clinical research has explored it in students (with some improvements in memory test scores) and in aging adults (with improvements in MMSE scores in some trials). Dose used in most studies: 50 to 200 mcg daily.

Ingredient 7: St. John's Wort

St. John's Wort (Hypericum perforatum) is included in Memopryl's formula for its associations with serotonin, dopamine, and norepinephrine pathway support — mechanisms that contribute to mood stability, motivation, and cognitive clarity. The active compounds studied include hypericin and hyperforin.

The evidence for St. John's Wort in mild-to-moderate depression is reasonably established in European research, with several meta-analyses finding it comparable to low-dose SSRIs for mild depression. For cognitive support specifically, the evidence is less direct — its contribution to Memopryl's formula is more likely through mood and motivation pathways than direct memory mechanisms.

The drug interaction profile of St. John's Wort is the primary clinical concern in this formula. St. John's Wort induces CYP3A4, CYP2C9, and P-glycoprotein — drug-metabolizing enzymes and transporters that process a large proportion of prescription medications. This means it can reduce the plasma concentration of drugs that depend on these pathways, potentially decreasing their efficacy. Documented interactions include SSRIs (serotonin syndrome risk when combined), warfarin and other anticoagulants (reduced anticoagulant effect), oral contraceptives (reduced contraceptive efficacy), certain antiretrovirals, cyclosporine, and digoxin. This is not a complete list. Any adult taking prescription medication should discuss St. John's Wort with their prescribing physician before starting this supplement.

Ingredient 8: L-Glutamine

L-Glutamine is a conditionally essential amino acid and the most abundant amino acid in circulation. In the brain, it serves as a precursor to both glutamate (the brain's primary excitatory neurotransmitter) and GABA (the primary inhibitory neurotransmitter). It also functions as a secondary energy substrate for neurons when glucose availability is limited.

L-Glutamine's inclusion in a nootropic formula is mechanistically consistent — supporting neurotransmitter substrate availability and brain energy metabolism. The research on L-Glutamine specifically for cognitive enhancement in healthy adults is limited compared to the other ingredients in this formula. Its contribution is likely supportive rather than driving.

L-Glutamine is generally well-tolerated at supplemental doses. In clinical contexts, it is used at much higher doses (10 to 30 g daily) for gastrointestinal and immune support; typical nootropic supplements use 100 mg to 500 mg.

The Stack Logic: Why These Eight Ingredients Together

Memopryl's formula reflects a multi-pathway approach to cognitive support. The design targets four mechanisms simultaneously: cerebrovascular support and antioxidant activity (Ginkgo Biloba), neuronal membrane integrity and structural support (Phosphatidylserine), memory consolidation through adaptive neurotrophic mechanisms (Bacopa Monnieri), and cholinergic pathway optimization through a triple mechanism — increased choline supply (Alpha-GPC), synthesis support (ALCAR), and reduced acetylcholine breakdown (Huperzine-A). St. John's Wort addresses the serotonin/dopamine dimension. L-Glutamine supports neurotransmitter substrate availability.

The logic is coherent. The limitation is dosage opacity — confirming that this logic is executed at therapeutic dose ranges requires either label disclosure or third-party testing, neither of which is currently available for Memopryl.

For the practical question of whether this formula produces results, including what timelines to expect and what the research-informed realistic expectations look like, see the does Memopryl work article. For the complete safety and interaction profile, see the Memopryl side effects and drug interactions review. For how this formula compares to other nootropic options, see the comparison review. For a product using a different ingredient approach to cognitive support, the MemoryFuel review covers an energy-focused formulation without St. John's Wort.

Frequently Asked Questions

What are the ingredients in Memopryl?

Memopryl contains eight ingredients: Ginkgo Biloba, Phosphatidylserine, Bacopa Monnieri, Alpha-GPC, N-Acetyl-L-Carnitine (ALCAR), Huperzine-A, St. John's Wort, and L-Glutamine. Individual dosages are not publicly disclosed — the formula is a proprietary blend.

Does Memopryl disclose ingredient dosages?

No. Memopryl operates as a proprietary blend, meaning the total blend weight is listed but individual ingredient amounts are not. This is a transparency limitation relevant to anyone managing a supplement stack or tracking daily intake of specific compounds.

Which Memopryl ingredient has the strongest research support?

Bacopa Monnieri has the strongest evidence base for the specific outcome of memory consolidation, with multiple randomized controlled trials showing significant improvements in delayed recall at 300–450 mg daily over 12 or more weeks. Phosphatidylserine also carries an FDA-authorized qualified health claim (limited, not conclusive) related to cognitive function in older adults.

Why is Huperzine-A in Memopryl?

Huperzine-A inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine, thereby raising acetylcholine levels in the brain. This mechanism closely resembles how FDA-approved prescription Alzheimer's drugs work, which is also why it requires a physician conversation for anyone already taking those medications.

What is the role of St. John's Wort in Memopryl?

St. John's Wort supports serotonin and dopamine pathways contributing to mood and cognitive clarity. It also carries a significant drug interaction profile — interacting with SSRIs, warfarin, oral contraceptives, and other prescription drugs through CYP450 enzyme induction. Any adult on prescription medication should discuss it with their physician before use.